SEARCH

SEARCH BY CITATION

References

  • 1
    Gruchalla RS. Drug allergy. J Allergy Clin Immunol 2003;111:548559.
  • 2
    Levine BB. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med 1966;275:11151125.
  • 3
    Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994;331:12721285.
  • 4
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:23482357.
  • 5
    Torres MJ, Mayorga C, Fernandez TD, Cornejo-Garcia JA, Antunez C, Valenzuela M et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006;19:119130.
  • 6
    Leyva L, Torres MJ, Posadas S, Blanca M, Besso G, O’Valle F et al. Anticonvulsant-induced toxic epidermal necrolysis. Monitoring of the immunologic response. J Allergy Clin Immunol 2000;105:157165.
  • 7
    Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004;114:12091215.
  • 8
    Mayorga C, Torres MJ, Corzo JL, Sanchez-Sabate E, Alvarez J, Vera A et al. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin. Ann Allergy Asthma Immunol 2003;91:8691.
  • 9
    Posadas SJ, Leyva L, Torres MJ, Rodriguez JL, Bravo I, Rosal M et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000;106:769776.
  • 10
    Gaspard I, Guinnepain MT, Laurent J, Bachot N, Kerdine S, Bertoglio J et al. IL-4 and IFN-γ mRNA induction in human peripheral lymphocytes specific for β-lactam antibiotics in immediate or delayed hypersensitivity reactions. J Clin Immunol 2000;20:107116.
  • 11
    Mauri-Helweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 1995;155:462472.
  • 12
    Brugnolo F, Annunziato F, Sampognaro S, Campi P, Manfredi M, Matucci A et al. Highly Th2-skewed cytokine profile of betalactam-specific T cells from nonatopic subjects with adverse-drug reactions. J Immunol 1999;163:10531059.
  • 13
    Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000;21:479483.
  • 14
    Brockow K, Romano A, Blanca A, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:4551.
  • 15
    Torres MJ, Corzo JL, Leyva L, Mayorga C, Garcia-Martin FJ, Antunez C et al. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol Dis 2003;30:124131.
  • 16
    Escoubet-Lozach L, Glass CK, Wasserman SI. The role of transcription factors in allergic inflammation. J Allergy Clin Immunol 2002;110:553564.
  • 17
    Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM et al. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001;292:19071910.
  • 18
    Li-Weber M, Salgame P, Hu C, Davydov IV, Laur O, Klevenz S et al. Th2 specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the hyuman IL-4 promoter. J Immunol 1998;161:13801389.
  • 19
    Zhang DH, Yang L, Ray A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol 1998;161:38173821.
  • 20
    Monteleone I, Monteleone G, Del Vecchio Blanco G, Vavassori P, Cucchiara S, MacDonald TT et al. Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa. Gut 2004;53:10901095.
  • 21
    Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn’s disease. J Exp Med 2002;195:11291143.
  • 22
    Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res 2006;84:10271036.
  • 23
    Christodoulopoulos P, Cameron L, Nakamura Y, Lemiere C, Muro S, Dugas M et al. Th2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J Allergy Clin Immunol 2001;107:586591.
  • 24
    Nakamura Y, Christodoulopoulos P, Cameron L, Wright E, Lavigne F, Toda M et al. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J Allergy Clin Immunol 2000;105:11461152.
  • 25
    Macaubas C, Lee PT, Smallacombe TB, Holt BJ, Wee C, Sly PD et al. Reciprocal patterns of allergen-induced GATA-3 expression in peripheral blood mononuclear cells from atopics vs. non-atopics. Clin Exp Allergy 2002;32:97106.
  • 26
    Ishizaki K, Yamada A, Yoh K, Nakano T, Shimohata H, Maeda A et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J Immunol 2007;178:605612.
  • 27
    Posadas SJ, Padial A, Torres MJ, Mayorga C, Leyva L, Sanchez E et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002;109:155161.
  • 28
    Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-Maf is responsible for tissue-specific expression of interleukin-4. Cell 1996;85:973983.
  • 29
    Peng SL. The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 2006;3:8795.
  • 30
    Kawashima M, Miossec P. mRNA quantification of T-bet, GATA-3, IFN-γ, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity. J Clin Immunol 2005;25:209214.
  • 31
    Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, Miyagishi M et al. Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones. Immunol Cell Biol 2005;83:536541.
    Direct Link:
  • 32
    Iacopino AM, Doxey D, Cutler CW, Nares S, Stoever K, Fojt J et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:7383.
  • 33
    Vesce F, Pavan B, Lunghi L, Giovannini G, Scapoli C, Piffanelli A et al. Inhibition of amniotic interleukin-6 and prostaglandin E2 release by ampicillin. Obstet Gynecol 2004;103:108113.